Gallegos-Catalán, J.; Warnken, Z.; Bahamondez-Canas, T.F.; Moraga-Espinoza, D.
Innovating on Inhaled Bioequivalence: A Critical Analysis of the Current Limitations, Potential Solutions and Stakeholders of the Process. Pharmaceutics 2021, 13, 1051.
https://doi.org/10.3390/pharmaceutics13071051
AMA Style
Gallegos-Catalán J, Warnken Z, Bahamondez-Canas TF, Moraga-Espinoza D.
Innovating on Inhaled Bioequivalence: A Critical Analysis of the Current Limitations, Potential Solutions and Stakeholders of the Process. Pharmaceutics. 2021; 13(7):1051.
https://doi.org/10.3390/pharmaceutics13071051
Chicago/Turabian Style
Gallegos-Catalán, Jonattan, Zachary Warnken, Tania F. Bahamondez-Canas, and Daniel Moraga-Espinoza.
2021. "Innovating on Inhaled Bioequivalence: A Critical Analysis of the Current Limitations, Potential Solutions and Stakeholders of the Process" Pharmaceutics 13, no. 7: 1051.
https://doi.org/10.3390/pharmaceutics13071051
APA Style
Gallegos-Catalán, J., Warnken, Z., Bahamondez-Canas, T. F., & Moraga-Espinoza, D.
(2021). Innovating on Inhaled Bioequivalence: A Critical Analysis of the Current Limitations, Potential Solutions and Stakeholders of the Process. Pharmaceutics, 13(7), 1051.
https://doi.org/10.3390/pharmaceutics13071051